Skip to main content
. 2016 Apr 11;2016:6594039. doi: 10.1155/2016/6594039

Figure 1.

Figure 1

Negative interaction between the CNV-67048 and oral contraceptive use on EOC risk. The subjects who carried 2-copy CNV-67048 and never used oral contraceptive were defined as reference. The loss copy of CNV-67048 significantly interacted with null oral contraceptive use on EOC risk.